Oncolytic herpes simplex virus and therapeutic uses thereof | Patent Number 11147846

US 11147846 B2
Application Number16578178
Publication NumberUS 20200113956 A1
Pendency2 years, 1 month
Filled DateSep 20, 2019
Priority DateSep 8, 2011
Publication DateApr 16, 2020
Expiration DateSep 7, 2031
Inventor/ApplicantsIan J. Mohr
Matthew Mulvey
ExaminesGILL, RACHEL B
Art Unit1648
Technology Center1600
Assignments
New York University
Current
Janssen Biotech Inc.
Current
Janssen Biotech Inc.New York University
Original
Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.